Electronic Data Capture (EDC) using cellular technology: Implications for clinical trials and practice, and preliminary experience with the m-Womac ® Index in hip and knee OA patients

被引：11

作者：

Bellamy N. ^{[1
]}

Wilson C. ^{[1
]}

Hendrikz J. ^{[1
]}

Patel B. ^{[2
]}

Dennison S. ^{[2
]}

机构：

[1] Centre of National Research on Disability and Rehabilitation Medicine (CONROD), University of Queensland, Brisbane

[2] Exco InTouch, Harlow

来源：

Inflammopharmacology | 2009年 / 17卷 / 2期

关键词：

EDC; Health status measurement; Mobile phone; Osteoarthritis; WOMAC[!sup]®[!/sup;

D O I：

10.1007/s10787-008-8045-4

中图分类号：

学科分类号：

摘要：

Aim: The capture, analysis and utilisation of health status information are attended by logistic considerations and interpretation challenges. We report a preliminary evaluation of cellular technology in capturing WOMAC® NRS 3.1 Index data. Methods:: A Java midlet for delivering the WOMAC ® NRS3.1 Index on Nokia-6300, Motorola-V3 and Samsung-A711 mobile phones was developed by Exco InTouch. Following task orientation, patients completed the paper-based WOMAC® (p-WOMAC®) questionnaire, and then the three mobile phonebased WOMAC® (m-WOMAC®) applications, in random order. Results:: All 12 patients (age range = 55-82 years) successfully completed the m-WOMAC ® Index on each of the three phones, and all were found acceptable by patients. With respect to m-WOMAC® mean overall rank score, no significant difference was found between the 3 phones (Friedman's chi square (2 df) = 2.2, p = 0.34) however, Motorola V3 was favoured with the best mean rank. Pearson correlation between the average p-WOMAC® and average m-WOMAC® score was 0.996. Conclusions:: Patient reported ratings indicated the m-WOMAC® application performed well on all three phones. EDC provides unique opportunities for using quantitative measurement in both clinical practice and research. © 2009 Birkhäuser Verlag, Basel.

引用

页码：93 / 99

页数：6

共 54 条

[1]

Abasomi A., Goodridge W., Asika O., Wireless networks for surveillance, data capture and data management in the human immunodeficiency virus epidemic care and treatment programmes, Afr J Med Sci, 35, SUPPL., pp. 149-152, (2006)

[2]

Altman R.D., Criteria for classification of clinical osteoarthritis, J Rheumatol Suppl, pp. 10-12, (1991)

[3]

Altman R.D., Hochberg M.C., Moskowitz R.W., Schnitzer T.J., Recommendations for the medical management of osteoarthritis of the hip and knee. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, Arthritis Rheum, 43, pp. 1905-1915, (2000)

[4]

National Arthritis and Musculoskeletal Conditions Advisory Group (NAMSCAG), Evidence to Support the National Action Plan for Osteoarthritis, Rheumatoid Arthritis and Osteoporosis: Opportunities to Improve Health-Related Quality of Life and Reduce the Burden of Disease and Disability, (2004)

[5]

Begg A., Drummond G., Tiplady B., Assessment of postsurgical recovery after discharge using a pen computer diary, Anaesthesia, 58, 11, pp. 1101-1105, (2003)

[6]

Bellamy N., The WOMAC Knee and Hip Osteoarthritis Indices: Development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices, Clin Exp Rheumatol, 23, SUPPL. 39, pp. 148-153, (2005)

[7]

Bellamy N., Principles of Outcome Assessment, Rheumatology, pp. 11-20, (2008)

[8]

Bellamy N., WOMAC® User Guide IX, pp. 1-76, (2008)

[9]

Bellamy N., Wilson C., International estimation of Patient Acceptable Symptom Severity (PASS75): The Reflect Study, Int Med Journal, 37, SUPPL. 2, (2007)

[10]

Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L., Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, 15, pp. 1833-1840, (1988)

← 1 2 3 4 5 6 →